Basic Information
ID: ALA3625533
Type: Binding
Description: Inhibition of Staphylococcus aureus FabI assessed as reduction in inhibition of reduction of trans-2-octenoyl N-acetylcysteamine substrate by spectrophotometry
Organism: Staphylococcus aureus
Activity Charts
Bioactivity
Activity Types for Assay ALA3625533
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 337.35 | 1.12 | 1.12 |
| 289.55 | 5.14 | 5.14 |
| 402.28 | 5.86 | 5.86 |
| 362.21 | 5.05 | 5.05 |
| 376.24 | 5.06 | 5.06 |
| 402.28 | 5.86 | 5.86 |
| 372.76 | 4.31 | 4.31 |
| 386.79 | 4.32 | 4.32 |
| 412.83 | 5.12 | 5.12 |
| 266.68 | 3.23 | 3.23 |
| 363.20 | 5.32 | 5.32 |
| 342.78 | 4.97 | 4.97 |
| 322.36 | 4.63 | 4.63 |
| 363.20 | 5.32 | 5.32 |
| 363.20 | 5.32 | 5.32 |
| 353.33 | 4.23 | 4.23 |
| 338.79 | 5.56 | 5.56 |
| 328.75 | 5.16 | 5.16 |
| 328.75 | 5.16 | 5.16 |
| 339.78 | 4.96 | 4.96 |
| 344.82 | 5.63 | 5.63 |
| 344.82 | 5.63 | 5.63 |
| 327.77 | 4.89 | 4.89 |
| 304.77 | 5.21 | 5.21 |
| 304.77 | 5.06 | 5.06 |
| 359.21 | 5.91 | 5.91 |
| 349.17 | 5.50 | 5.50 |
| 360.20 | 5.30 | 5.30 |
| 318.37 | 5.22 | 5.22 |
| 308.33 | 4.81 | 4.81 |
| 319.36 | 4.61 | 4.61 |
| 359.21 | 5.91 | 5.91 |
| 349.17 | 5.50 | 5.50 |
| 360.20 | 5.30 | 5.30 |
| 359.21 | 5.91 | 5.91 |
| 349.17 | 5.50 | 5.50 |
| 360.20 | 5.30 | 5.30 |
| 362.21 | 5.05 | 5.05 |
| 376.24 | 5.06 | 5.06 |
| 402.28 | 5.86 | 5.86 |
| 418.32 | 6.33 | 6.33 |
| 452.34 | 6.57 | 6.57 |
| 341.79 | 4.71 | 4.71 |
| 355.82 | 4.72 | 4.72 |
| 381.86 | 5.52 | 5.52 |
| 397.90 | 5.98 | 5.98 |
| 431.92 | 6.23 | 6.23 |
| 321.38 | 4.36 | 4.36 |
| 335.40 | 4.37 | 4.37 |
| 361.44 | 5.17 | 5.17 |
| 377.48 | 5.64 | 5.64 |
| 411.50 | 5.88 | 5.88 |
| 362.21 | 5.05 | 5.05 |
| 376.24 | 5.06 | 5.06 |